4.7 Article

Germline findings in patients with advanced malignancies screened with paired blood-tumour testing for personalised treatment approaches

Related references

Note: Only part of the references are listed.
Review Oncology

Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer

Kerstin Rhiem et al.

Summary: The GC-HBOC has established a multigene panel for the analysis of familial breast and ovarian cancer risk genes. An interdisciplinary team of experts evaluated data on risk modification in the presence of pathogenic mutations to provide clinical recommendations for patient counseling and care at GC-HBOC centers. The goal is to better assess individual disease risk and recommend risk-adapted preventive/therapeutic measures.

BREAST CARE (2022)

Article Multidisciplinary Sciences

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly- informed therapies despite heterogeneity

Lino Moehrmann et al.

Summary: We conducted comprehensive molecular characterization of 70 patients with cancer of unknown primary and identified substantial mutational heterogeneity and commonly mutated cancer-related genes. Our data demonstrate the clinical value of molecular analysis and recommend off-label therapy for a subset of patients, resulting in improved progression-free survival.

NATURE COMMUNICATIONS (2022)

Article Genetics & Heredity

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia

B. Dalmasso et al.

Summary: This study supports the role of ATM as a melanoma predisposition gene, with LOF variants suggesting a moderate-risk.

GENETICS IN MEDICINE (2021)

Article Oncology

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

Elise M. Fiala et al.

Summary: This study reported the results of prospective DNA sequencing in pediatric solid tumor patients, identifying germline variants associated with high and moderate penetrance genes, some of which were unexpected. Most patients with positive results underwent clinical genetics consultation, and some relatives also underwent cascade testing.

NATURE CANCER (2021)

Article Medicine, General & Internal

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Talia Golan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Biochemical Research Methods

Improved indel detection in DNA and RNA via realignment with ABRA2

Lisle E. Mose et al.

BIOINFORMATICS (2019)

Article Biochemistry & Molecular Biology

Pathogenic Germline Variants in 10,389 Adult Cancers

Kuan-lin Huang et al.

Article Multidisciplinary Sciences

The landscape of genomic alterations across childhood cancers

Susanne N. Groebner et al.

NATURE (2018)

Article Biochemical Research Methods

Strelka2: fast and accurate calling of germline and somatic variants

Sangtae Kim et al.

NATURE METHODS (2018)

Article Medicine, General & Internal

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

K. Moore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Meeting Abstract Oncology

Germline ATM mutations in families with early-onset and familial gastroesophageal and colorectal cancers.

Michael J. Hall et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir et al.

NATURE MEDICINE (2017)

Article Medicine, General & Internal

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Mark Robson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Oncology

Pancreatic non-functioning neuroendocrine tumor: a new entity genetically related to Lynch syndrome

Anna Serracant Barrera et al.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)

Article Biochemical Research Methods

SeqPurge: highly-sensitive adapter trimming for paired-end NGS data

Marc Sturm et al.

BMC BIOINFORMATICS (2016)

Article Oncology

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

Douglas B. Johnson et al.

CANCER IMMUNOLOGY RESEARCH (2016)

Article Oncology

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA

Kasmintan A. Schrader et al.

JAMA ONCOLOGY (2016)

Article Biotechnology & Applied Microbiology

The Ensembl Variant Effect Predictor

William McLaren et al.

GENOME BIOLOGY (2016)

Article Medicine, General & Internal

Germline Mutations in Predisposition Genes in Pediatric Cancer

Jinghui Zhang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Cell Biology

Personalized genomic analyses for cancer mutation discovery and interpretation

Sian Jones et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Genetics & Heredity

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Robert C. Green et al.

GENETICS IN MEDICINE (2013)